• HOME

  • MODELS

    • Alzheimer's disease
    • Neuronal plasticity
    • Parkinson's disease
    • ALS
    • Stroke
    • Huntington's disease
    • Multiple Sclerosis
    • Central Myelination
    • Induced Peripheral Neuropathies
    • Nerve crush
    • Adrenoleukodystrophy
    • Multiple System Atrophy
    • Lysosomal diseases
    • BBB Penetrance
  • MODE OF ACTION

  • PLATFORMS

  • ABOUT US

  • R&D

  • CONTACT

  • Plus

    Use tab to navigate through the menu items.
    NS-Baseline2020_white.png
    Neurones gabaergiques MAP2 rouge GAD67 vert (HD).jpg

    PRECLINICAL MODELS  |  CNS  |  HD

    Huntington's disease

    IN VITRO models​

    ​

    Primary culture of mesencephalic neurons (spiny neurons, GAD positive neurons) co-cultured with glial cells (astrocytes and microglia):

    • Glutamate injury

    • Growth factor deprivation

    Contact us

    Other
    models

    #CNS
    Alzheimer's
    disease

    #CNS
    Neuronal
    plasticity

    #CNS
    Parkinson's
    disease

    #CNS
    Amyotrophic
    Lateral
    Sclerosis

    #CNS
    Stroke

    #CNS
    Multiple
    Sclerosis

    #CNS
    Central
    Myelination

    #PNS
    Induced
    Peripheral
    Neuropathies

    #PNS
    Nerve
    crush

    #RARE DISEASES
    Adreno
    leukodystrophy

    #RARE DISEASES
    Multiple
    System
    Atrophy

    #RARE DISEASES
    Lysosomal
    diseases

    #BBB
    BBB
    penetrance

    #MODE OF ACTION
    CRISPR/Cas9

    #MODE OF ACTION
    Pharmacological
    tools

    #MODE OF ACTION
    siRNA

    Top

    CNS

      > Alzheimer's disease

      > Neuronal plasticity

      > Parkinson's disease

      > Amyotrophic Lateral Sclerosis

      > Stroke

      > Huntington's disease

      > Multiple Sclerosis

      > Central Myelination

    ​

    PNS

      > Induced Peripheral Neuropathies

      > Nerve crush

    RARE DISEASES

      > Adrenoleukodystrophy

      > Multiple System Atrophy

      > Lysosomal diseases

    ​

    BBB PENETRANCE

    ​

    MODE OF ACTION

      > CRISPR/Cas9

      > Pharmacological tools

      > siRNA

      > Biomolecular investigations

    PLATFORMS

      > In vitro platform

      > In vivo platform

      > Histology platform

      > EMG platform

      > Analytical analysis platform

      > Bio molecular analysis platform

      > Drug Development advisory

    NS-Baseline2020_white.png

    CONTACT US

    EMEA Office

    Neuro-Sys SAS (Headquarters)

    410 Chemin Départemental 60

    13120 Gardanne, France

    Email: info@neuro-sys.com

    Tel : +33 4 13 41 51 71

    • Blanc LinkedIn Icône

    US Office

    Neuro-Sys, Inc.

    50 Milk St, 16th floor

    Boston MA 02109, USA

    Email: info@neuro-sys.com

    Tel : +1 617-588-3257

    © 2022 Neuro-Sys SAS

    © 2022 Neuro-Sys Vivo SAS

    © 2022 Neuro-Sys Inc.

     

    Privacy Policy

    Proud member of:

    SCIENTIST_edited_edited.png
    science-exchange-logo-white_edited_edite
    BiocomCaliforniaLogo_Primary_edited.png
    CLSA_edited.png
    Brain-Awareness-Week-logo-color-rgb_edited.png